15
Participants
Start Date
March 9, 2022
Primary Completion Date
July 27, 2024
Study Completion Date
December 31, 2025
Psilocybin
Oral, single administration, dosage 25 mg orally
Psychotherapy
The treatment regimen consists of a single administration of psilocybin orally combined with a supportive psychotherapy including 2 preparation sessions and 2 integration sessions
Care Dimensions, Danvers
Collaborators (2)
Oppenheimer Family Psychosocial Oncology and Palliative Care Research Grants
UNKNOWN
Usona Institute
OTHER
Carey and Claudia Turnbull Family Foundation
UNKNOWN
Heffter Research Institute
OTHER
George Sarlo Foundation
UNKNOWN
RiverStyx Foundation
OTHER
Council on Spiritual Practices Fund at the San Francisco Foundation
UNKNOWN
Nikean Foundation
UNKNOWN
Jack Smith
UNKNOWN
Yvan Beaussant, MD, MSci
OTHER